You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 273 No. 12, March 22, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (29)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Costs and Effects of Long-term Oral Anticoagulant Treatment After Myocardial Infarction

Paul F. M. M. van Bergen, MD, PhD; Jan J. C. Jonker, MD; Ben A. van Hout, PhD; Ronald T. van Domburg; Jaap W. Deckers, MD, PhD; Aida J. Azar, PhD; Albert Hofman, MD, PhD

JAMA. 1995;273(12):925-928.


Abstract

Objective.
—To investigate the costs and effects of long-term oral anticoagulant treatment after myocardial infarction.

Design.
—Cost-effectiveness analysis, based on a randomized, double-blind, placebo-controlled trial.

Setting.
—Sixty Dutch hospitals.

Patients.
—A total of 3404 hospital survivors of acute myocardial infarction randomized within a median period of 4 days after discharge to either oral anticoagulant treatment or placebo. The mean follow-up was 37 months.

Intervention.
—Oral anticoagulant treatment aimed at a target international normalized ratio of 2.8 to 4.8.

Main Outcome Measurements.
—Costs of hospital stay during readmissions, costs related to major cardiologic interventions, and costs of oral anticoagulant treatment.

Results.
—The costs of oral anticoagulant treatment were estimated at 394 Dutch guilders (Dfl) per patient-year (Dfl1=US $0.58). Placebo patients stayed 18 830 days in the hospital compared with 15 083 days for anticoagulation patients. Average costs per patient of medical care during follow-up were estimated at Dfl 10784 for placebo patients and Dfl 9878 for anticoagulation patients.

Conclusions.
—Costs of long-term anticoagulant treatment are outweighed by the costs of prevented clinical events.

(JAMA. 1995;273:925-928)



Author Affiliations

From the ASPECT Coordinating Centre (Drs van Bergen and Jonker); Institute for Medical Technology Assessment, Erasmus University (Dr van Hout); Thoraxcentre, University Hospital Rotterdam (Drs Deckers and Azar and Mr van Domburg); and Erasmus University Medical School, Department of Epidemiology and Biostatistics (Drs van Bergen, Jonker, and Hofman), Rotterdam, the Netherlands.


Footnotes

Reprint requests to Rotterdam Medical Research Foundation (ROMERES), Mathenesserlaan 247, 3021 HC, Rotterdam, the Netherlands (Dr van Bergen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Renal Artery Stenosis: Cost-effectiveness of Diagnosis and Treatment
van Helvoort-Postulart et al.
Radiology 2007;244:505-513.
ABSTRACT | FULL TEXT  

Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation
Miller et al.
Eur Heart J Suppl 2005;7:C41-C54.
ABSTRACT | FULL TEXT  

State-of-the-Art Review : Secondary Prevention of Myocardial Infarction: Beneficial Effect of Combining Oral Anticoagulant Plus Aspirin: Therapy Based on Evidence
Altman et al.
CLIN APPL THROMB HEMOST 2000;6:126-134.
 

Cost-effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients With Nonvalvular Atrial Fibrillation
Gage et al.
JAMA 1995;274:1839-1845.
ABSTRACT  

Costs of Oral Anticoagulation Treatment After Myocardial Infarction
Bussey and Chiquette
JAMA 1995;274:1588-1589.
ABSTRACT  

Cardiovascular Disease
Gore and Dalen
JAMA 1995;273:1662-1664.
ABSTRACT  

Anticoagulation Reduces Costs and Time in Hospital After MI
Journal Watch Cardiology 1995;1995:18-18.
FULL TEXT  

ANTICOAGULATION SAVES COSTS AFTER MI
JWatch General 1995;1995:2-2.
FULL TEXT  

Economics and Efficacy in Choosing Oral Anticoagulants or Aspirin After Myocardial Infarction
Cairns and Markham
JAMA 1995;273:965-967.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.